Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?

Table 3

M-mode echocardiographic data of patients compared to controls.

M-mode		N	Mean	±SD	t-test	P value
LVIDD (cm)	Patients	24	3.84	1.18	4.860	0.001**
	Control	20	2.52	0.29
LVIDS (cm)	Patients	24	3.13	1.24	4.223	0.001**
	Control	20	1.95	0.06
EDV (mL)	Patients	24	79.16	55.25	3.645	<0.05*
	Control	20	33.90	2.26
ESV (mL)	Patients	24	50.79	42.29	3.806	0.001**
	Control	20	14.70	1.78
EF%	Patients	24	45	17.46	4.385	0.001**
	Control	20	62.25	2.44
FS%	Patients	24	22.91	10.72	3.855	0.001**
	Control	20	32.25	1.40
LA/AO	Patients	24	1.78	0.88	2.006	>0.05
	Control	20	0.88	0.30

∗∗Highly significant, *Significant. LVIDD: left ventricular internal diameter in diastole, LVIDS: left ventricular internal diameter in systole, EF: ejection fraction, FS: fraction shortening, AO: aortic annulus, LA: left atrium, EDV: end-diastolic volume, ESV: end-systolic volume, LA: left atrium, and Ao: aorta.